lactic acid has been researched along with d-arg-dmt-lys-phe-nh2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, W; Kuang, X; Liu, H; Sun, Y; Wang, Z; Zhou, S | 1 |
| Ewer, N; Ford, R; Hoareau, GL; Johnson, MA; Neff, LP; Patel, N; Van Brocklin, MW; Vapniarsky, N; Williams, TK; Youngquist, ST | 1 |
2 other study(ies) available for lactic acid and d-arg-dmt-lys-phe-nh2
| Article | Year |
|---|---|
SS-31 peptide enables mitochondrial targeting drug delivery: a promising therapeutic alteration to prevent hair cell damage from aminoglycosides.
Topics: Aminoglycosides; Animals; Cell Death; Diterpenes; Drug Delivery Systems; Ear, Inner; Gentamicins; Hair Cells, Auditory; Hearing Loss; Lactic Acid; Lateral Line System; Membrane Potential, Mitochondrial; Mitochondria; Nanoparticles; Oligopeptides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protective Agents; Zebrafish | 2017 |
Elamipretide mitigates ischemia-reperfusion injury in a swine model of hemorrhagic shock.
Topics: Animals; Balloon Occlusion; Disease Models, Animal; Endovascular Procedures; Hemorrhage; Lactic Acid; Norepinephrine; Reperfusion Injury; Resuscitation; Shock, Hemorrhagic; Swine | 2023 |